
30/01/2025
We are thrilled to announce our €14M Series A funding round led by Panakès Partners SGR to transform breast reconstruction following lumpectomy.
This milestone marks a transformative step forward in our mission to revolutionize breast reconstruction and augmentation through our innovative bio-absorbable implant technology, creating new opportunities to advance women’s health and breast care.
We are enthusiastic to welcome the support of Panakès Partners, the EIC Fund, and other esteemed investors who share our vision of improving the quality of life for breast cancer survivors worldwide.
We are also excited to welcome Dr. Sanjay Kakkar as our new CEO, bringing invaluable leadership and experience to drive Tensive’s growth and expansion.
This achievement brings us closer to making a lasting impact, reinforcing our commitment to restoring confidence and femininity, and improving the quality of life for breast cancer patients.
Read more about our Series A round here: https://www.tensivemed.com/tensive-raises-14m-series-a-financing-round/
Tensive raises €14,000,000 Series A Financing Round led by Panakès Partners SGR to transform breast reconstruction following lumpectomy.